3M announced on Tuesday, Dec. 20, that it will end the manufacturing of Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) which are also called “forever chemicals.” These manufactured chemicals are often used as ingredients in almost everything - from mobile phones to semiconductors.
This is present in most everyday products, although PFAS has been linked to many illnesses, including heart problems, cancer, and even low birthweights. The company is aiming to make a full exit from producing this chemical by the end of 2025.
As explained by Reuters, PFAS are called forever chemicals since they are types of substances that do not break down easily. They are almost impossible to destroy due to their strong carbon-fluorine bonds.
In recent years, researchers found a dangerous level of this substance in drinking water, food, and soils across the country. Now, 3M made the decision to stop the production of PFAS amid the increasing legal pressures over damages resulting from the use of PFAS.
In fact, 3M was among the companies that were sued by the attorney general of California to recover clean-up costs. DuPont de Nemours Inc. is another major firm to be included in the legal suit.
As damages from PFAS continue to be more visible to everyone, the pressure on companies to give up the chemicals has grown in recent years. Many investors have already sent out letters to urge companies to discontinue the use of the forever chemicals.
"This is a moment that demands the kind of innovation 3M is known for and while PFAS can be safely made and used, we also see an opportunity to lead in a rapidly evolving external regulatory and business landscape to make the greatest impact for those we serve," Mike Roman, 3M’s chairman and chief chief executive officer, said in a press release.
The 3M chief added, “This action is another example of how we are positioning 3M for continued sustainable growth by optimizing our portfolio, innovating for our customers, and delivering long-term value for our shareholders."


Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Lee Seung-heon Signals Caution on Rate Hikes, Supports Higher Property Taxes to Cool Korea’s Housing Market
Anta Sports Expands Global Footprint With Strategic Puma Stake
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data 



